ciprofloxacin has been researched along with Arthropathies in 34 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Excerpt | Relevance | Reference |
---|---|---|
"To report a case of possible ciprofloxacin-induced arthropathy in an adult patient with cystic fibrosis (CF)." | 7.68 | Arthropathy secondary to ciprofloxacin in an adult cystic fibrosis patient. ( Pleasants, RA; Samuelson, WM; Whitaker, MS, 1993) |
"Food and Drug Administration regulations state that ciprofloxacin hydrochloride may cause arthropathies." | 3.70 | Ciprofloxacin as a therapeutic modality in pediatric burn wound infections: efficacious or contraindicated? ( Desai, M; Edgar, P; Heggers, JP; Herndon, DN; John, SD; Klein, GL; Villarreal, C; Wolf, S, 1998) |
"To report a case of possible ciprofloxacin-induced arthropathy in an adult patient with cystic fibrosis (CF)." | 3.68 | Arthropathy secondary to ciprofloxacin in an adult cystic fibrosis patient. ( Pleasants, RA; Samuelson, WM; Whitaker, MS, 1993) |
"To determine the safety of ciprofloxacin in paediatric patients in relation to arthropathy, any other adverse events (AEs) and drug interactions." | 2.47 | Ciprofloxacin safety in paediatrics: a systematic review. ( Adefurin, A; Choonara, I; Jacqz-Aigrain, E; Sammons, H, 2011) |
"5 and 6 h after dosing and the drug was still detectable in plasma 48 h after dosing (0." | 1.30 | Quinolone-induced arthropathy: exposure of magnesium-deficient aged rats or immature rats, mineral concentrations in target tissues and pharmacokinetics. ( Förster, C; Günther, T; Lozo, E; Merker, HJ; Schwabe, R; Stahlmann, R; Vormann, J; Zippel, U, 1997) |
"2." | 1.30 | The comparative arthropathy of fluoroquinolones in dogs. ( Hashimoto, K; Minami, T; Owen, K; Takizawa, T; Yamashita, S, 1999) |
"Ciprofloxacin use can cause an acute reversible arthropathy, but in this study there is no evidence that its use can cause a delayed arthropathy or any permanent joint damage." | 1.29 | Ciprofloxacin use: acute arthropathy and long-term follow up. ( Karande, S; Kshirsagar, NA, 1996) |
"Ciprofloxacin was also studied for its potential to act as an abortifacient when given orally or parenterally to cynomolgus monkeys." | 1.28 | Ciprofloxacin: toxicologic evaluation of additional safety data. ( Schluter, G, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (11.76) | 18.7374 |
1990's | 15 (44.12) | 18.2507 |
2000's | 10 (29.41) | 29.6817 |
2010's | 3 (8.82) | 24.3611 |
2020's | 2 (5.88) | 2.80 |
Authors | Studies |
---|---|
Bartolomé-Álvarez, J | 1 |
Solves-Ferriz, V | 1 |
Gómez-Junyent, J | 1 |
Rigo-Bonnin, R | 1 |
Benavent, E | 1 |
Soldevila, L | 1 |
Padullés, A | 1 |
Cabo, X | 1 |
Tubau, F | 1 |
Ariza, J | 1 |
Murillo, O | 1 |
Fuster, D | 1 |
Soriano, A | 1 |
Garcia, S | 1 |
Piera, C | 1 |
Suades, J | 1 |
Rodríguez, D | 1 |
Martinez, JC | 1 |
Mensa, J | 1 |
Campos, F | 1 |
Pons, F | 1 |
Adefurin, A | 1 |
Sammons, H | 1 |
Jacqz-Aigrain, E | 1 |
Choonara, I | 1 |
Malamitsi, J | 1 |
Papadopoulos, A | 1 |
Vezyrgianni, A | 1 |
Dalianis, K | 1 |
Boutsikou, M | 1 |
Giamarellou, H | 1 |
Nagai, A | 1 |
Miyazaki, M | 1 |
Morita, T | 1 |
Furubo, S | 1 |
Kizawa, K | 1 |
Fukumoto, H | 1 |
Sanzen, T | 1 |
Hayakawa, H | 1 |
Kawamura, Y | 1 |
Postnikov, SS | 1 |
Semykin, SIu | 1 |
Nazhimov, VP | 1 |
Novichkova, GA | 1 |
Sarda, L | 1 |
Crémieux, AC | 1 |
Lebellec, Y | 1 |
Meulemans, A | 1 |
Lebtahi, R | 1 |
Hayem, G | 1 |
Génin, R | 1 |
Delahaye, N | 1 |
Huten, D | 1 |
Le Guludec, D | 1 |
von Keutz, E | 1 |
Rühl-Fehlert, C | 1 |
Drommer, W | 1 |
Rosenbruch, M | 1 |
Britton, KE | 2 |
Das, SS | 1 |
Solanki, KK | 1 |
Legout, L | 1 |
Senneville, E | 1 |
Stern, R | 1 |
Yazdanpanah, Y | 1 |
Savage, C | 1 |
Roussel-Delvalez, M | 1 |
Rosele, B | 1 |
Migaud, H | 1 |
Mouton, Y | 1 |
Arda, B | 1 |
Sipahi, OR | 1 |
Yamazhan, T | 1 |
Emircan, I | 1 |
Aksu, K | 1 |
Ulusoy, S | 1 |
Camp, KA | 1 |
Miyagi, SL | 1 |
Schroeder, DJ | 1 |
Castera, L | 1 |
Pauwels, A | 1 |
Haettich, B | 1 |
Debenes, B | 1 |
Lévy, VG | 1 |
Orenstein, DM | 1 |
Pattishall, EN | 1 |
Noyes, BE | 1 |
Kurland, G | 1 |
Hartigan, ER | 1 |
Yu, VL | 1 |
Samuelson, WM | 1 |
Pleasants, RA | 1 |
Whitaker, MS | 1 |
Linseman, DA | 1 |
Hampton, LA | 1 |
Branstetter, DG | 1 |
Redmond, AO | 1 |
Karande, S | 1 |
Kshirsagar, NA | 1 |
Förster, C | 1 |
Schwabe, R | 1 |
Lozo, E | 1 |
Zippel, U | 1 |
Vormann, J | 1 |
Günther, T | 1 |
Merker, HJ | 1 |
Stahlmann, R | 1 |
Salam, MA | 1 |
Dhar, U | 1 |
Khan, WA | 1 |
Bennish, ML | 1 |
Heggers, JP | 1 |
Villarreal, C | 1 |
Edgar, P | 1 |
Wolf, S | 1 |
Klein, GL | 1 |
John, SD | 1 |
Desai, M | 1 |
Herndon, DN | 1 |
Takizawa, T | 1 |
Hashimoto, K | 1 |
Minami, T | 1 |
Yamashita, S | 1 |
Owen, K | 1 |
Iakovlev, VP | 1 |
Segers, B | 1 |
Olamazadeh, S | 1 |
Thirion, M | 1 |
Lambert, J | 1 |
Sonmezoglu, K | 1 |
Sonmezoglu, M | 1 |
Halac, M | 1 |
Akgün, I | 1 |
Türkmen, C | 1 |
Onsel, C | 1 |
Kanmaz, B | 1 |
Solanki, K | 1 |
Uslu, I | 1 |
Gulati, S | 1 |
Marwaha, RK | 1 |
Schaad, UB | 1 |
Stoupis, C | 1 |
Wedgwood, J | 1 |
Tschaeppeler, H | 1 |
Vock, P | 1 |
Fulton, B | 1 |
Moore, LL | 1 |
Schluter, G | 1 |
Jawad, AS | 1 |
Alfaham, M | 1 |
Holt, ME | 1 |
Goodchild, MC | 1 |
Greenberg, RN | 1 |
Kennedy, DJ | 1 |
Reilly, PM | 1 |
Luppen, KL | 1 |
Weinandt, WJ | 1 |
Bollinger, MR | 1 |
Aguirre, F | 1 |
Kodesch, F | 1 |
Saeed, AM | 1 |
3 reviews available for ciprofloxacin and Arthropathies
Article | Year |
---|---|
Ciprofloxacin safety in paediatrics: a systematic review.
Topics: Adolescent; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Child; Child, Preschool; Ciprofloxacin | 2011 |
Potential quinolone-induced cartilage toxicity in children.
Topics: Anti-Infective Agents; Cartilage; Child; Child, Preschool; Ciprofloxacin; Clinical Trials as Topic; | 1994 |
[Use of ciprofloxacin in the treatment and prevention of surgical infections].
Topics: Anti-Infective Agents; Bacterial Infections; Bone Diseases, Infectious; Ciprofloxacin; Humans; Joint | 1999 |
4 trials available for ciprofloxacin and Arthropathies
Article | Year |
---|---|
Usefulness of 99mTc-ciprofloxacin scintigraphy in the diagnosis of prosthetic joint infections.
Topics: Aged; Arthroplasty; Ciprofloxacin; Female; Humans; Joint Diseases; Male; Organotechnetium Compounds; | 2011 |
[On fluoroquinolones treatment safety in children (clinical, morphological and catamnesis data)].
Topics: Adolescent; Age Factors; Anemia, Aplastic; Anti-Infective Agents; Body Height; Cartilage; Child; Chi | 2002 |
Inability of 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases.
Topics: Adult; Aged; Arthritis, Infectious; Bone Diseases; Ciprofloxacin; Diagnosis, Differential; False Pos | 2003 |
Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis.
Topics: Adolescent; Amdinocillin Pivoxil; Anti-Infective Agents; Arthralgia; Child; Child, Preschool; Ciprof | 1998 |
27 other studies available for ciprofloxacin and Arthropathies
Article | Year |
---|---|
[Increase in methicillin-resistant and ciprofloxacin-susceptible Staphylococcus aureus in osteoarticular, skin and soft tissue infections].
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Joint Diseases; Meth | 2020 |
Efficacy and Therapeutic Drug Monitoring of Continuous Beta-Lactam Infusion for Osteoarticular Infections Caused by Fluoroquinolone-Resistant Pseudomonas aeruginosa: A Prospective Cohort Study.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Bone Diseases, Infectious; Ciprofloxacin; Cohort Studies; | 2020 |
The value of successive Infecton scans in assessing the presence of chronic bone and joint infection and in predicting its evolution after treatment and after a prolonged follow-up.
Topics: Adult; Aged; Arthrography; Blood Sedimentation; Bone and Bones; Bone Diseases, Infectious; C-Reactiv | 2011 |
Comparative articular toxicity of garenoxacin, a novel quinolone antimicrobial agent, in juvenile beagle dogs.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Cartilage, Articular; Ciprofloxacin; Dogs; Dos | 2002 |
Effects of ciprofloxacin on joint cartilage in immature dogs immediately after dosing and after a 5-month treatment-free period.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Cartilage, Articular; Ciprofloxacin; Dogs; Dos | 2004 |
Ability of (99m)tc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases.
Topics: Arthritis, Infectious; Bone Diseases; Ciprofloxacin; Colloids; Diagnosis, Differential; Humans; Join | 2004 |
Treatment of bone and joint infections caused by Gram-negative bacilli with a cefepime-fluoroquinolone combination.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bone Diseases, Infectious; Cefepime; Cephalos | 2006 |
Salmonella enteritidis related prosthetic joint infection.
Topics: Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Joint Diseases; Joint Prosthesis; | 2006 |
[Arthropathy caused by fluoroquinolones in a patient after liver transplantation].
Topics: Adult; Ciprofloxacin; Humans; Joint Diseases; Knee Joint; Liver Transplantation; Male; Postoperative | 1993 |
Safety of ciprofloxacin in children with cystic fibrosis.
Topics: Administration, Oral; Adolescent; Alkaline Phosphatase; Child; Ciprofloxacin; Cystic Fibrosis; Drug | 1993 |
Arthropathy secondary to ciprofloxacin in an adult cystic fibrosis patient.
Topics: Adult; Ciprofloxacin; Cystic Fibrosis; Humans; Joint Diseases; Male | 1993 |
Quinolone-induced arthropathy in the neonatal mouse. Morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin.
Topics: Animals; Animals, Newborn; Anti-Infective Agents; Body Weight; Cartilage, Articular; Ciprofloxacin; | 1995 |
Risk-benefit experience of ciprofloxacin use in pediatric patients in the United Kingdom.
Topics: Acute Disease; Anti-Infective Agents; Child; Ciprofloxacin; Humans; Joint Diseases; Pseudomonas Infe | 1997 |
Ciprofloxacin use: acute arthropathy and long-term follow up.
Topics: Acute Disease; Adverse Drug Reaction Reporting Systems; Anti-Infective Agents; Child; Child, Prescho | 1996 |
Quinolone-induced arthropathy: exposure of magnesium-deficient aged rats or immature rats, mineral concentrations in target tissues and pharmacokinetics.
Topics: Age Factors; Animals; Anti-Infective Agents; Calcium; Cartilage; Ciprofloxacin; Contraindications; F | 1997 |
Ciprofloxacin as a therapeutic modality in pediatric burn wound infections: efficacious or contraindicated?
Topics: Adolescent; Age Factors; Anti-Infective Agents; Biopsy; Burns; Child; Child, Preschool; Ciprofloxaci | 1998 |
The comparative arthropathy of fluoroquinolones in dogs.
Topics: Animals; Anti-Infective Agents; Body Weight; Ciprofloxacin; Dogs; Eating; Fluoroquinolones; Joint Di | 1999 |
[A new method of scintigraphy].
Topics: Adult; Aged; Aged, 80 and over; Bone Diseases, Infectious; Ciprofloxacin; Female; Humans; Joint Dise | 2000 |
Usefulness of 99mTc-ciprofloxacin (infecton) scan in diagnosis of chronic orthopedic infections: comparative study with 99mTc-HMPAO leukocyte scintigraphy.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Bone and Bones; Child; Child, Preschool; Chron | 2001 |
Post-exposure anthrax prophylaxis.
Topics: Abdominal Pain; Animals; Anthrax; Anthrax Vaccines; Anti-Bacterial Agents; Anti-Infective Agents; Ba | 2001 |
Ciprofloxacin current status in pediatric practice.
Topics: Bacterial Infections; Child; Ciprofloxacin; Contraindications; Humans; Joint Diseases | 1992 |
Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin.
Topics: Adolescent; Adult; Cartilage, Articular; Child; Ciprofloxacin; Cystic Fibrosis; Female; Humans; Join | 1991 |
Comment: Ciprofloxacin excretion into breast milk.
Topics: Adolescent; Ciprofloxacin; Cystic Fibrosis; Female; Humans; Joint Diseases; Lactation; Milk, Human | 1990 |
Ciprofloxacin: toxicologic evaluation of additional safety data.
Topics: Abortion, Spontaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Ciprofloxacin; Dogs; | 1989 |
Cystic fibrosis and drug-induced arthropathy.
Topics: Adolescent; Ciprofloxacin; Cystic Fibrosis; Female; Humans; Joint Diseases; Pseudomonas Infections | 1989 |
Arthropathy in a patient with cystic fibrosis taking ciprofloxacin.
Topics: Adolescent; Ciprofloxacin; Cystic Fibrosis; Female; Humans; Joint Diseases; Knee Joint; Pseudomonas | 1987 |
Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Cellulitis; Ciprofloxacin; Enterob | 1987 |